Biotech gains amid buyout chatter, upbeat clinical trial results By: CNBC.com News August 24, 2016 at 12:48 PM EDT Buyout chatter and optimistic trial results boosted the biotechnology sector on Wednesday. Read More >> Related Stocks: Incyte Corp Insys Therapeutics Inc Nasdaq Biotechnology Ishares ETF Sarepta Therapeutics